Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Pancreatic Adenocarcinoma”

256 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 256 results

Not applicableStudy completedNCT06344299
What this trial is testing

Predictors for Low Rates of Surgical Resection in Elderly Patients With Resectable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Fudan University 5,302
Early research (Phase 1)UnknownNCT03703063
What this trial is testing

Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Benaroya Research Institute 30
Early research (Phase 1)Looking for participantsNCT06756035
What this trial is testing

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Who this might be right for
Mesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more
Context Therapeutics Inc. 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT04986930
What this trial is testing

MFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaPancreatic Cancer Non-resectable
Asan Medical Center 92
Not applicableUnknownNCT02781012
What this trial is testing

Project Survival-Prospective Biomarker Discovery

Who this might be right for
Pancreatic NeoplasmsPancreatic CancerPancreatitis+2 more
Pancreatic Cancer Research Team 436
Testing effectiveness (Phase 2)Active Not RecruitingNCT05604560
What this trial is testing

A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer

Who this might be right for
Pancreatic Cancer
Lei Zheng 25
Not applicableLooking for participantsNCT06574620
What this trial is testing

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Who this might be right for
Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal Adenocarcinoma+1 more
British Columbia Cancer Agency 200
Testing effectiveness (Phase 2)Study completedNCT02178709
What this trial is testing

A Phase II Study of Neoadjuvant FOLFIRINOX

Who this might be right for
Resectable Pancreatic Ductal Adenocarcinoma
Indiana University 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT02446093
What this trial is testing

Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma

Who this might be right for
Borderline Resectable Pancreatic Adenocarcinoma
Candel Therapeutics, Inc. 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07415525
What this trial is testing

IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerBorderline Resectable Pancreatic Adenocarcinoma
Zhejiang University 40
Testing effectiveness (Phase 2)Looking for participantsNCT05825066
What this trial is testing

Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreas AdenocarcinomaBorderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Adenocarcinoma
Wake Forest University Health Sciences 64
Testing effectiveness (Phase 2)Study completedNCT03496662
What this trial is testing

BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Washington University School of Medicine 40
Not applicableStudy completedNCT03273374
What this trial is testing

Intraoperative Radiation Therapy for Resectable Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Adenocarcinoma
Gangnam Severance Hospital 42
Not applicableActive Not RecruitingNCT06090916
What this trial is testing

Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Stage III Pancreatic CancerPancreatic Adenocarcinoma Non-resectable
Jonsson Comprehensive Cancer Center 100
Testing effectiveness (Phase 2)Ended earlyNCT04176952
What this trial is testing

PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Neoplasms Pancreatic
Judith Dixon-Hughes 31
Testing effectiveness (Phase 2)Ended earlyNCT01760252
What this trial is testing

Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Beth Israel Medical Center 17
Testing effectiveness (Phase 2)Study completedNCT01959672
What this trial is testing

Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaResectable Pancreatic CarcinomaStage I Pancreatic Cancer+6 more
University of Nebraska 11
Testing effectiveness (Phase 2)Ended earlyNCT01206296
What this trial is testing

Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Medstar Health Research Institute 9
Testing effectiveness (Phase 2)WithdrawnNCT02850874
What this trial is testing

HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsPancreatic Adenocarcinoma
Wake Forest University Health Sciences
Not applicableNot Yet RecruitingNCT07034703
What this trial is testing

Prospective Cohort of Patients Treated Using Neoadjuvant Modified FOLFIRINOX 6 Cycles for Potentially Resectable Pancreatic Duct Adenocarcinoma, Candidate for Participation in the PANACHE02 Clinical Trial

Who this might be right for
Resectable Pancreatic Duct Adenocarcinoma
University Hospital, Rouen 820
Load More Results